Genetic variation in single nucleotide polymorphisms (SNPs) of CCL5 and CCR5 in patients with mCRC predicts the efficacy of the anti-epidermal growth factor receptor based on the location of the tumor (90). Here, CCR5 is linked to neoplasm.